JNJ-39588146

· Johnson & Johnson Pharmaceutical Research and Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-39588146, covering 2013-06-25 to 2013-06-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure [Phase 2]

See pricing